GLUE
#2359
Monte Rosa Therapeutics, Inc. - Common Stock
13.7 2 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.54%
Variación mensual
-17.55%
Variación en los últimos 6 meses
-20.28%
Cambio anual
+21.42%
Cierres anteriores
13.3 8
Open
13.6 5
Mínimo
13.6 2
Máximo
13.7 2
Volumen
152
Financials
- Market Capitalization 1.17 B
- Employee 173
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.75
Relación precio/flujo de caja
75.87
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2309 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 14.91 USD | -0.53% | -3.18% | -19.41% | +55.96% | 1.27 B USD | ||
| 2355 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 13.88 USD | -1.98% | -2.25% | +5.39% | +143.94% | 1.17 B USD | ||
| 2370 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.79 USD | -3.56% | -0.79% | +20.70% | +25.91% | 1.13 B USD | ||
| 2388 |  KURA Kura Oncology, Inc. - Common Stock | 12.62 USD | -0.32% | +1.45% | +39.91% | +57.95% | 1.12 B USD |